Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer

BACKGROUND: Prostate cancer (PCa) tumors harboring translocations of ETS family genes with the androgen responsive TMPRSS2 gene (ETS+ tumors) provide a robust biomarker for detecting PCa in approximately 70% of patients. ETS+ PCa express high levels of the androgen receptor (AR), yet PCa tumors lack...

Descripción completa

Detalles Bibliográficos
Autores principales: Berglund, Anders E., Rounbehler, Robert J., Gerke, Travis, Awasthi, Shivanshu, Cheng, Chia-Ho, Takhar, Mandeep, Davicioni, Elai, Alshalalfa, Mohammed, Erho, Nicholas, Klein, Eric A., Freedland, Stephen J., Ross, Ashley E., Schaeffer, Edward M., Trock, Bruce J., Den, Robert B., Cleveland, John L., Park, Jong Y., Dhillon, Jasreman, Yamoah, Kosj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760558/
https://www.ncbi.nlm.nih.gov/pubmed/30367117
http://dx.doi.org/10.1038/s41391-018-0103-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760558/
https://www.ncbi.nlm.nih.gov/pubmed/30367117
http://dx.doi.org/10.1038/s41391-018-0103-4

Ejemplares similares